Sanofi American Depositary Shares (Each representing one-half of
SNY Real Time Price USD$SNY is featured in our Top Gov Contract Recipients strategy.
All StrategiesRecent trades of SNY by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in SNY holdings by institutional investors
Quarterly net insider trading by SNY's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$1,590,000 Oct 20, 2025 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,050,000 Jul 21, 2025 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Manufacturing
-
$2,540,000 Apr 21, 2025 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$690,000 Jan 21, 2025 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,815,000 Oct 21, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$860,000 Jul 22, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$2,160,000 Apr 22, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$60,000 Feb 08, 2024 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Budget/Appropriations Health Issues Medicare/Medicaid
-
$880,000 Jan 22, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$1,520,000 Oct 18, 2023 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$1,870,000 Apr 20, 2022 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$850,000 Jan 20, 2022 Issue: None
-
$1,310,000 Oct 20, 2021 Issue: None
-
$980,000 Jul 21, 2021 Issue: None
-
$1,440,000 Apr 20, 2021 Issue: None
-
$700,000 Jan 20, 2021 Issue: None
-
$1,300,000 Oct 20, 2020 Issue: None
-
$860,000 Jul 20, 2020 Issue: None
-
$1,750,000 Apr 20, 2020 Issue: None
-
$783,000 Jan 21, 2020 Issue: None
-
$40,000 Jul 10, 2019 Issue: Pharmacy Copyright/Patent/Trademark
-
$1,668,000 Apr 22, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Budget/Appropriations Torts
-
$790,000 Jan 22, 2019 Issue: Torts Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,100,000 Jul 20, 2018 Issue: Health Issues Economics/Economic Development Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid
-
$2,030,000 Apr 20, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$600,000 Jan 22, 2018 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,260,000 Oct 20, 2017 Issue: Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$740,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Trade (domestic/foreign) Torts Taxation/Internal Revenue Code
-
$1,896,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Consumer Issues/Safety/Products Pharmacy Torts Medicare/Medicaid
-
$470,000 Jan 20, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Pharmacy Taxation/Internal Revenue Code
-
$31,000 Apr 02, 2016 Issue: Medical/Disease Research/Clinical Labs Homeland Security Health Issues
-
$990,000 Jan 11, 2016 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Animals Pharmacy Trade (domestic/foreign)
-
$940,000 Jan 05, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Economics/Economic Development Animals Medical/Disease Research/Clinical Labs Pharmacy
-
$1,170,000 Oct 14, 2015 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Economics/Economic Development
-
$840,000 Jul 17, 2015 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Economics/Economic Development
-
$1,370,000 Apr 16, 2015 Issue: Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Pharmacy
-
$840,000 Jan 16, 2015 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$940,000 Oct 16, 2014 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Economics/Economic Development Medical/Disease Research/Clinical Labs
-
$720,000 Jul 09, 2014 Issue: Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Economics/Economic Development Copyright/Patent/Trademark Pharmacy
-
$1,570,000 Apr 17, 2014 Issue: Pharmacy Animals Budget/Appropriations Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$790,000 Jan 20, 2014 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Manufacturing Torts
-
$1,310,000 Oct 15, 2013 Issue: Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Manufacturing Copyright/Patent/Trademark
-
$800,000 Oct 15, 2013 Issue: Animals Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Manufacturing
-
$1,590,000 Aug 13, 2013 Issue: Medical/Disease Research/Clinical Labs Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,800,000 Jul 18, 2013 Issue: Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Economics/Economic Development
-
$710,000 Oct 15, 2012 Issue: Health Issues Economics/Economic Development Taxation/Internal Revenue Code Animals Medicare/Medicaid
-
$1,420,000 Jul 19, 2012 Issue: Medical/Disease Research/Clinical Labs Animals Health Issues Taxation/Internal Revenue Code Manufacturing Copyright/Patent/Trademark Economics/Economic Development
-
$750,000 Apr 16, 2012 Issue: Torts Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Manufacturing Copyright/Patent/Trademark Medical/Disease Research/Clinical Labs
-
$710,000 Jan 17, 2012 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,100,000 Oct 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medical/Disease Research/Clinical Labs Torts Medicare/Medicaid
-
$930,000 Jul 19, 2011 Issue: Torts Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$1,860,000 Apr 20, 2011 Issue: Torts Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$623,000 Mar 16, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$950,000 Jan 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
-
$1,380,000 Oct 18, 2010 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
-
$620,000 Oct 13, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$870,000 Jul 19, 2010 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Pharmacy
-
$630,000 Jul 16, 2010 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
-
$1,580,000 Apr 20, 2010 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Pharmacy
-
$920,000 Apr 20, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,430,000 Jan 20, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy
-
$608,000 Jan 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,470,000 Oct 19, 2009 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Pharmacy Copyright/Patent/Trademark
-
$593,000 Oct 08, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,580,000 Jul 17, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Pharmacy
-
$633,000 Jul 13, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,460,000 Apr 20, 2009 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Pharmacy
-
$578,000 Apr 15, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,160,000 Jan 21, 2009 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$594,000 Jan 14, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,270,000 Dec 18, 2008 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
-
$1,480,000 Dec 18, 2008 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
-
$1,190,000 Dec 18, 2008 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Environment/Superfund Copyright/Patent/Trademark
-
$565,000 Oct 17, 2008 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$460,000 Jul 21, 2008 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
-
$440,000 Apr 18, 2008 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$650,000 Feb 14, 2008 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$3,560,000 Feb 11, 2008 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Veterans Defense Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Budget/Appropriations
-
$650,000 Aug 14, 2007 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$3,560,000 Aug 13, 2007 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Veterans Financial Institutions/Investments/Securities Defense Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$3,674,234 Feb 13, 2007 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Financial Institutions/Investments/Securities
-
$600,000 Feb 01, 2007 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$2,006,189 Aug 17, 2006 Issue: Financial Institutions/Investments/Securities Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Veterans Medicare/Medicaid Pharmacy
-
$500,000 Aug 08, 2006 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$2,380,000 Feb 17, 2006 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy Medical/Disease Research/Clinical Labs Torts Copyright/Patent/Trademark
-
$500,000 Feb 14, 2006 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,480,699 Aug 29, 2005 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy Torts
-
$500,000 Aug 16, 2005 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,344,000 Feb 08, 2005 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
-
$500,000 Feb 07, 2005 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$500,000 Aug 19, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,570,000 Aug 12, 2004 Issue: Budget/Appropriations Trade (domestic/foreign) Health Issues Medicare/Medicaid
-
$500,000 Apr 12, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,270,712 Feb 26, 2004 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations
-
$360,000 Aug 14, 2003 Issue: Taxation/Internal Revenue Code Health Issues Trade (domestic/foreign)
-
$1,300,000 Aug 14, 2003 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Torts
-
$360,000 Feb 14, 2003 Issue: Taxation/Internal Revenue Code Health Issues
-
$1,320,000 Feb 14, 2003 Issue: Health Issues Trade (domestic/foreign) Medicare/Medicaid Pharmacy Medical/Disease Research/Clinical Labs
-
$360,000 Aug 14, 2002 Issue: Taxation/Internal Revenue Code Health Issues
-
$1,120,000 Aug 14, 2002 Issue: Medical/Disease Research/Clinical Labs Law Enforcement/Crime/Criminal Justice Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Medicare/Medicaid Labor Issues/Antitrust/Workplace
SNY Estimated quarterly lobbying spending
SNY Revenue by Segment or Geography
New SNY patent grants
-
Patent Title: Display screen with a graphical user interface Nov. 11, 2025
-
Patent Title: Display screen with a graphical user interface Oct. 14, 2025
-
Patent Title: Medical injector Jun. 17, 2025
-
Patent Title: Display screen with an animated computer icon Jun. 03, 2025
-
Patent Title: Display screen with an animated computer icon May. 27, 2025
-
Patent Title: Display screen with an animated graphical user interface Mar. 11, 2025
-
Patent Title: Assembly tool Dec. 10, 2024
-
Patent Title: Injection device Sep. 24, 2024
-
Patent Title: Medical injection device Jun. 06, 2023
-
Patent Title: Display panel portion with an animated computer icon Jul. 26, 2022
-
Patent Title: Display panel portion with an animated computer icon Jul. 19, 2022
-
Patent Title: Display panel portion with an animated computer icon May. 31, 2022
-
Patent Title: Display panel portion with an animated computer icon May. 31, 2022
-
Patent Title: Display panel portion with an animated computer icon May. 31, 2022
-
Patent Title: Display panel portion with an animated computer icon May. 24, 2022
-
Patent Title: Display panel portion with an animated computer icon May. 24, 2022
-
Patent Title: Display panel portion with an animated computer icon Apr. 19, 2022
-
Patent Title: Display panel portion with an animated computer icon Apr. 05, 2022
-
Patent Title: Injection device Aug. 03, 2021
-
Patent Title: Injection device Jan. 26, 2021
-
Patent Title: Display screen or portion thereof with a graphical user interface Jul. 07, 2020
-
Patent Title: Cap of an injection device Nov. 19, 2019
-
Patent Title: Injection device Nov. 12, 2019
-
Patent Title: Injection device Nov. 12, 2019
-
Patent Title: Epha2 receptor antagonist antibodies Nov. 13, 2018
-
Patent Title: Electrical stimulation device Oct. 16, 2018
-
Patent Title: Process for preparing genetically transformed yeasts capable of producing a molecule of interest at a high titre Jun. 12, 2018
-
Patent Title: Otamixaban formulations with improved stability Jun. 12, 2018
-
Patent Title: Immuno imaging agent for use with antibody-drug conjugate therapy Jun. 05, 2018
-
Patent Title: Assembly for a drug delivery device and method of operating the same Jun. 05, 2018
-
Patent Title: Display assembly and dispensing device Jun. 05, 2018
-
Patent Title: Exendin-4 derivatives as selective peptidic dual glp-1/glucagon receptor agonists May. 29, 2018
-
Patent Title: 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis May. 15, 2018
-
Patent Title: Injection device May. 01, 2018
-
Patent Title: Electrical stimulation device Apr. 24, 2018
-
Patent Title: Medicament injection device Mar. 13, 2018
-
Patent Title: Medicament injection device Nov. 14, 2017
-
Patent Title: Injection device Nov. 14, 2017
-
Patent Title: Injection device Aug. 15, 2017
-
Patent Title: Medicament injection device Jun. 13, 2017
-
Patent Title: Medicament injection device May. 16, 2017
-
Patent Title: Medicament injection device Mar. 21, 2017
-
Patent Title: Autoinjector Sep. 20, 2016
-
Patent Title: Autoinjector Sep. 13, 2016
-
Patent Title: Autoinjector without cap Aug. 30, 2016
-
Patent Title: Autoinjector without cap Aug. 30, 2016
-
Patent Title: Package Aug. 23, 2016
-
Patent Title: Medicament injection device Apr. 05, 2016
-
Patent Title: Cap for a medicament injection device Jan. 26, 2016
-
Patent Title: Medicament injection device Sep. 29, 2015
Federal grants, loans, and purchases
- $176,565 2025-09-09 00:00:00 Agency: Department of State
- $24,873,330 2025-09-08 00:00:00 Agency: Department of Health and Human Services
- $1,939 2025-09-03 00:00:00 Agency: Department of Justice
- $3,142 2025-07-11 00:00:00 Agency: Department of Justice
- $72,385 2025-07-07 00:00:00 Agency: Department of Health and Human Services
- $588,756 2025-06-16 00:00:00 Agency: Department of Health and Human Services
- $7,613 2025-05-29 00:00:00 Agency: Department of Health and Human Services
- $7,921 2025-05-29 00:00:00 Agency: Department of Health and Human Services
- $11,173 2025-05-27 00:00:00 Agency: Department of State
- $21,178 2025-05-15 00:00:00 Agency: Department of State
- $21,178 2025-05-13 00:00:00 Agency: Department of State
- $20,787 2025-05-08 00:00:00 Agency: Department of State
- $20,787 2025-05-08 00:00:00 Agency: Department of State
- $18,549 2025-05-08 00:00:00 Agency: Department of State
- $22,259 2025-05-08 00:00:00 Agency: Department of State
- $11,401 2025-05-08 00:00:00 Agency: Department of State
- $18,549 2025-05-08 00:00:00 Agency: Department of State
- $18,549 2025-05-08 00:00:00 Agency: Department of State
- $14,897 2025-05-06 00:00:00 Agency: Department of State
- $11,129 2025-05-06 00:00:00 Agency: Department of State
- $22,259 2025-05-06 00:00:00 Agency: Department of State
- $18,549 2025-05-06 00:00:00 Agency: Department of State
- $11,401 2025-04-28 00:00:00 Agency: Department of State
- $18,549 2025-04-24 00:00:00 Agency: Department of State
- $22,259 2025-04-24 00:00:00 Agency: Department of State
- $18,549 2025-04-24 00:00:00 Agency: Department of State
- $18,549 2025-04-24 00:00:00 Agency: Department of State
- $6,902 2025-04-15 00:00:00 Agency: Department of Justice
- $0 2025-03-12 00:00:00 Agency: Department of Health and Human Services
- $14,897 2025-02-25 00:00:00 Agency: Department of State
- $80,000 2025-02-11 00:00:00 Agency: Department of Justice
- $8,885,214 2025-01-31 00:00:00 Agency: Department of Health and Human Services
- $8,472 2024-12-30 00:00:00 Agency: Department of Health and Human Services
- $8,731 2024-12-30 00:00:00 Agency: Department of Health and Human Services
- $0 2024-11-20 00:00:00 Agency: Department of Veterans Affairs
- $104,733 2024-10-18 00:00:00 Agency: Department of Veterans Affairs
- $38,845 2024-10-09 00:00:00 Agency: Smithsonian Institution
- $521,520 2024-09-17 00:00:00 Agency: Department of State
- $521,520 2024-09-17 00:00:00 Agency: Department of State
- $282,019 2024-09-05 00:00:00 Agency: Department of Health and Human Services
- $680,955 2024-09-04 00:00:00 Agency: Department of Health and Human Services
- $4,335 2024-09-03 00:00:00 Agency: Department of Justice
- $3,491 2024-08-26 00:00:00 Agency: Department of Justice
- $97,980 2024-08-22 00:00:00 Agency: Department of Health and Human Services
- $1,371 2024-08-16 00:00:00 Agency: Department of Justice
- $172,097 2024-07-25 00:00:00 Agency: Department of Health and Human Services
- $1,665 2024-07-24 00:00:00 Agency: Department of Justice
- $4,132,574 2024-07-15 00:00:00 Agency: Department of Health and Human Services
- $5,877 2024-07-02 00:00:00 Agency: Department of Justice
- $980 2024-06-06 00:00:00 Agency: Department of Justice
Estimated quarterly amount awarded to SNY from public contracts
Recent insights relating to SNY
Recent picks made for SNY stock on CNBC
ETFs with the largest estimated holdings in SNY
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $SNY stock a Buy, Sell, or Hold?
- What is the price target for $SNY stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $SNY stock?
- Who owns the most shares of $SNY stock?
- What funds own $SNY stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SNY Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.